Similarly, E-cadherin expression persists in higher-grade aggressive prostate cancer [20,29], while the loss of E-cadherin signaling is observed in epithelial-to-mesenchymal transition, providing an example of tumor phenotype plasticity [20,45]. This evidence concerns the gene CDH1 and prostate cancer.